ClinicalTrials.gov
ClinicalTrials.gov Menu

Tarceva and Capecitabine for Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00125021
Recruitment Status : Completed
First Posted : July 29, 2005
Last Update Posted : November 2, 2009
Sponsor:
Collaborators:
Genentech, Inc.
Roche Global Development
Brigham and Women's Hospital
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by:
Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2004
  Actual Study Completion Date : September 2008